SMX Security Matters plc vs Zimmer Biomet Holdings Inc — how do they compare? SMX Security Matters plc trades at $3.79 (market cap $4.13M), while Zimmer Biomet Holdings Inc trades at $89.14 (market cap $16.95B). The key difference: Zimmer Biomet Holdings Inc is far larger — about 4104.1× SMX Security Matters plc's market cap, and Zimmer Biomet Holdings Inc pays a 1.08% dividend while SMX Security Matters plc pays none. Which is the better fit depends on your goals — on Pluang, investors hold SMX Security Matters plc for 21 Days and Zimmer Biomet Holdings Inc for 89 Days on average.
| SMX | ZBH | |
|---|---|---|
Market Cap | $4.13M | $16.95B |
Volume | 124,362 | 2,505,240 |
Sector | Industrials | Health |
52-Week High | $74.08K | $103.98 |
52-Week Low | $3.79 | $79.58 |
Typical Hold Time | 21 Days | 89 Days |
Enterprise Value | -$27.20M | $24.02B |
Dividend Yield | — | 1.08% |
Signals from Pluang's Aura AI — not financial advice
SMX trades at $3.79, down 2.82% with bearish technical signals despite oversold RSI readings. The company shows severe financial distress with zero revenue, negative $169.18M net income, and negative ROE of -819.22%. Recent news highlights SMX's Digital Material Passport technology gaining media attention from Forbes, TIME, and Boston Herald for recycled plastic verification and 'Made in America' authentication solutions.
The outlook remains highly speculative given the absence of revenue and substantial losses. While technology innovation presents long-term potential, immediate risks include cash burn sustainability and dependence on financing activities. Investors should approach with caution given the fundamental weaknesses and bearish technical indicators.
Zimmer Biomet (ZBH) trades at $89.14, up 0.73% today, with a bearish technical signal but strong recent earnings beats. The stock shows robust fundamentals with a 69.87% gross margin and 2025 revenue of $8.23B, though net income margin has declined from 2023 peaks. Analyst consensus is a Buy with a $103.11 target, indicating potential upside, supported by a steady dividend and institutional accumulation.
The outlook is mixed: valuation metrics like a P/E of 21.57 appear reasonable, and earnings momentum is positive, but technical weakness and rising debt-to-asset ratios pose risks. Investment appeal hinges on execution of commercial transformations and procedure volume recovery, balancing growth prospects against competitive and operational headwinds.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
SMX Security Matters plc is a digital authentication and tracking technology company that uses a chemical-based, invisible marker system to trace and verify products across global supply chains. Their technology creates a 'digital twin' of physical products, used for quality control, counterfeiting prevention, and ensuring sustainability compliance from raw materials to final sale. The company's solutions are applied across various industries, including precious materials, luxury goods, and fast-moving consumer goods.
Read more on SMX →Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →